Five things for pharma marketers to know: Monday, September 25, 2017

The FDA declines to approve an opioid and a treatment for rheumatoid arthritis; KKR closes WebMD buyout; 60% of teens have received the HPV vaccine

Healthcare agencies re-evaluate tactics to retain talent

The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.

4 Ways to Create Adherence Programs That Lead to Long-Term Change

4 Ways to Create Adherence Programs That Lead to Long-Term Change

How can marketers do more with less, or otherwise convince skeptical executives that more resources will lead to long-term change?

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

The health insurance startup launched a campaign this week that urges people to get covered.

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

Facebook itself has more than six million health-related groups.



Jeanne Martel, president and managing partner of ClinicalMind, talks about her experience as a woman in the workplace in this conversation with Jaimy Lee, MM&M's executive editor. The questions and topic were created and selected by the MM&M editorial staff. The video is sponsored by ClinicalMind.


Five things for pharma marketers to know: Friday, September 22, 2017

Five things for pharma marketers to know: Friday, September 22, 2017

Express Scripts' Miller says new models needed to pay for CAR-T; FDA warns about Intercept drug deaths; CVS puts limits on opioid scripts

New pharma CEOs to face payer, pricing challenges

New pharma CEOs to face payer, pricing challenges

They are tasked with addressing an increasingly tough payer environment and ongoing criticism of the industry's drug-pricing practices.

Wieden+Kennedy and The Atlantic win ADCOLOR's Ad of the Year for "Typecast"

Wieden+Kennedy and The Atlantic win ADCOLOR's Ad of the Year for "Typecast"

"Blood Equality" for GMHC by FCB Health was another honoree for Ad of the Year.

Five things for pharma marketers to know: Thursday, September 21, 2017

Five things for pharma marketers to know: Thursday, September 21, 2017

Nestle to refocus Galderma's skin health R&D; Amazon is reportedly in talks with PBMs; most Americans do not actively read science news

Co-pay cards unlock the key to patient engagement

Co-pay cards unlock the key to patient engagement

Beyond providing access, co-pay cards represent a starting point to more powerful patient engagement.

At ADCOLOR, 'Five Woke Women' challenge perceptions of identity in the workplace

At ADCOLOR, 'Five Woke Women' challenge perceptions of identity in the workplace

A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.

Five things for pharma marketers to know: Wednesday, September 20, 2017

Five things for pharma marketers to know: Wednesday, September 20, 2017

Pfizer sues J&J over Remicade contracts; drugmakers trim sales forces for rare-disease drugs; Roche's oncology business under siege from biosimilars

New Cologuard ad tries humor to make colon screening accessible

New Cologuard ad tries humor to make colon screening accessible

Exact Sciences has found success by marketing Cologuard in ads airing on networks like MSNBC, CNN, and Fox News.

Five things for pharma marketers to know: Tuesday, September 19, 2017

Five things for pharma marketers to know: Tuesday, September 19, 2017

Only three of the seven FDA-approved biosimilars are available for sale; Teva to sell off women's health portfolio; the FDA approves GSK's COPD combo

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

UDG Healthcare acquires MicroMass, for up to $75.8 million

UDG Healthcare acquires MicroMass, for up to $75.8 million

The company also this year has purchased Vynamic and Cambridge BioMarketing.

Five things for pharma marketers to know: Monday, September 18, 2017

Five things for pharma marketers to know: Monday, September 18, 2017

Insurers rarely require prior authorization for opioids; court of appeals voids J&J win in Advil ads suit; new California law to address drug pricing

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Is your brand's voice, male, female, human or mineral?

Is your brand's voice, male, female, human or mineral?

The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.

Five things for pharma marketers to know: Friday, September 15, 2017

Five things for pharma marketers to know: Friday, September 15, 2017

The FDA approves first cancer biosimilar; it also approves Bayer's new lymphoma drug; clinical-trial participation for gynecological cancer drops